… Although not yet commercially available in the United States, it is expected to be before
2008. Up to 250 mg (per application) applied topically, 3 times a day, produces total daily …

… Although it is difficult to estimate the overall prevalence of genital human papillomavirus (…
genital warts are present in approximately 1% of sexually active adults in the United States and …

… states and have confirmed that the Melbourne findings are part of a national trend. In this
study there were 6389 new cases of genital warts … the proportion of genital warts diagnosed in …

… genital HPV infections cost the United States $6 billion annually. … a therapy for genital warts,
especially urethral warts, despite not … not recommended as first line therapy for genital warts. …

… genital warts are a common sexually transmitted viral disease. We describe the patterns of
treatment for initial presentations of external genital warts (… million in the United States 6 and …

… United States have clinically apparent genital warts [38]. The average time to development
of new anogenital warts … with HPV types 6 or 11 develop genital warts, and many of the risk …

… Vulvar condylomata from case series in the United States are typically of HPV types 6
and ll, whereas vulvar carcinomas from similarly selected series are most often HPV type 16."*"* …

… genital warts and anogenital and oropharyngeal cancers. An estimated 1.4 million Americans
have genital warts … In the United States, several approaches are under way to measure the …

… In the United States and Australia, the cumulative incidence was 7.2% and 4.4% among …
not only high-grade genital lesions but also GWs. Genital warts have a short incubation period …

… The search strategy was based on three terms: genital warts, economic burden and
patients’ … Articles on genital warts were also captured through the specific MeSH term ‘condylomata …